2021 THE YEAR IN REVIEW


After year of milestones, biotech businesses anticipate big 2022.

South Dakota’s bioscience industry is thriving both in spite of the pandemic – and because of it.

“The last year has shown the potential we’ve seen in the state for bioscience growth start to be realized,” said Joni Ekstrum, executive director of South Dakota Biotech, state affiliate of the international BIO organization.

“We saw a number of key developments within the industry, but we also are investing in the future in a big way – collaborating with other industries,
supporting startups and connecting with our communities.”

Full Report Here
 
Back to News